Pacer Advisors’s Kite Pharma, Inc. KITE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
Sell
-936
Closed -$168K 1392
2017
Q3
$168K Sell
936
-4,915
-84% -$685K 0.01% 1032
2017
Q2
$607K Buy
5,851
+1,083
+23% +$88.4K 0.06% 489
2017
Q1
$374K Buy
+4,768
New +$295K 0.05% 662

Pacer Advisors's KITE Position: Q4 2017 in Review

Pacer Advisors sold out of Kite Pharma, Inc. (KITE) in Q4 2017, closing a stake of 936 shares — an estimated $168K sold.

Pacer Advisors first reported a position in KITE in Q1 2017 and held it in 3 quarters. The position peaked at $607K in Q2 2017. 0 funds tracked by Wall St. Rank hold KITE as of Q4 2017.

  • Pacer Advisors reported no remaining Kite Pharma, Inc. position as of Q4 2017 after selling out during the quarter.
  • Pacer Advisors sold 936 Kite Pharma, Inc. shares in Q4 2017, an estimated $168K.
  • Pacer Advisors first reported a position in Kite Pharma, Inc. in Q1 2017 and held it in 3 quarters.
  • Pacer Advisors's Kite Pharma, Inc. position peaked at $607K in Q2 2017.
  • 0 funds tracked by Wall St. Rank held Kite Pharma, Inc. as of Q4 2017.

Based on Pacer Advisors's 13F filing for Q4 2017, filed 14 Feb 2018.